Tab. 1: Registrierte klinische CAR-NK-Studien (https://clinicaltrials.gov/, abgerufen am 16.07.2020).

Studien-Nr.PhaseTargetBehandlungStartdatumOrt
USA
NCT00995137ICD19B-ALLOkt 09St Jude Children's Research Hospital, Memphis, Tennessee
NCT03056339I/IICD19Leukämie, LymphomJun 17MD Anderson Cancer Center, Houston, Texas
NCT04050709IPD-L1TumorJul 19Chan Soon-Shiong Institute for Medicine, El Segundo, California
NCT04052061ICD19DLBLSep 19Chan Soon-Shiong Institute for Medicine, El Segundo, California
NCT04390399IIPD-L1Pankreas KarzinomJun 20Chan Soon-Shiong Institute for Medicine, El Segundo, California
NCT04023071I-AML, LymphomOkt 19UC San Diego, San Diego, California | University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota | MD Anderson Cancer Center, Houston, Texas |
Swedish Cancer Institute, Seattle, Washington 
China
NCT02742727I/IICD7Leukämie, LymphomMrz 16PersonGen BioTherapeutics (Suzhou) Co., Ltd., Suzhou, Jiangsu
NCT02839954I/IIMUC1TumorJul 16PersonGen BioTherapeutics (Suzhou) Co., Ltd., Suzhou, Jiangsu
NCT02892695I/IICD19Leukämie, LymphomSep 16PersonGen BioTherapeutics (Suzhou) Co., Ltd., Suzhou, Jiangsu
NCT02944162I/IICD33AMLOkt 16PersonGen BioTherapeutics (Suzhou) Co., Ltd., Suzhou, Jiangsu
NCT03415100INKG2D-LigandTumorJan 18Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong
NCT03656705I-Lungenkarzinom, nicht-kleinzelligSep 18The first Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan
NCT03692663IPSMAProstata KarzinomDez 18Allife Medical Science and Technology Co., Ltd., Beijing
NCT03824951ICD19LymphomFeb 19Allife Medical Science and Technology Co., Ltd. | Beijing Cancer Hospital
NCT03824964ICD19/CD22LymphomFeb 19Allife Medical Science and Technology Co., Ltd. | Beijing Cancer Hospital
NCT03692767ICD22LymphomMrz 19Allife Medical Science and Technology Co., Ltd., Beijing
NCT03690310ICD19LymphomMrz 19Allife Medical Science and Technology Co., Ltd., Beijing
NCT03692637IMesothelinEpitheliales Ovarialkarzinom Mrz 19Allife Medical Science and Technology Co., Ltd., Beijing
NCT03940820I/IIROBO1TumorMai 19Radiation Therapy Department, Suzhou Cancer Center, Suzhou Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu
NCT03941457I/IIROBO1Pankreas KarzinomMai 19Department of Radiology, Shanghai Ruijin Hospital, Shanghai
NCT03940833I/IIBCMAMultiples MyelomMai 19Department of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, Jiangsu
NCT04324996I/IINKG2D Ligand, S-ProteinCOVID-19Mrz 20Chongqing Public Health Medical Center, Chongqing
Europa
NCT03383978IHER2HER2-positives GlioblastomDez 17Johann W. Goethe University Hospital, Department of Neurosurgery, Frankfurt | 
Johann W. Goethe University Hospital, Senckenberg Institute of Neurooncology, Frankfurt